The therapeutic significance of mutational signatures from DNA repair deficiency in cancer
Targeting DNA repair-deficient tumors is one of the most promising therapeutic strategies in cancer research; however, accurately predicting which tumors will respond can be a challenge. Here the authors present a review of the current state of knowledge in DNA repair deficiency across human cancers...
Guardado en:
Autores principales: | Jennifer Ma, Jeremy Setton, Nancy Y. Lee, Nadeem Riaz, Simon N. Powell |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/989e83e9fb614cad8639f2b928fc7330 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mutational signatures are jointly shaped by DNA damage and repair
por: Nadezda V. Volkova, et al.
Publicado: (2020) -
Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair
por: Justin Zonneville, et al.
Publicado: (2021) -
Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes
por: Nadeem Riaz, et al.
Publicado: (2017) -
Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma
por: Mari K. Halle, et al.
Publicado: (2021) -
Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers
por: Lin Yang, et al.
Publicado: (2021)